Zhitong Finance App News, Dacheng Biochemical Technology (00809.HK) issued an announcement. The company proposed to sell all of its shares in Changchun Dacheng Biotechnology through public tenders. As of the date of this announcement, Changchun Dacheng Biotechnology (i.e. the target company) has 70.96% and 29.04% of the interests respectively from Dacheng Biochemical Investment (Hong Kong) and Changchun Dahe (both wholly-owned subsidiaries of the company). After completion, the target company will no longer be a subsidiary of the company, and its financial performance, assets and liabilities will no longer be consolidated into the Group's comprehensive financial statements.

Zhitongcaijing · 18h ago
Zhitong Finance App News, Dacheng Biochemical Technology (00809.HK) issued an announcement. The company proposed to sell all of its shares in Changchun Dacheng Biotechnology through public tenders. As of the date of this announcement, Changchun Dacheng Biotechnology (i.e. the target company) has 70.96% and 29.04% of the interests respectively from Dacheng Biochemical Investment (Hong Kong) and Changchun Dahe (both wholly-owned subsidiaries of the company). After completion, the target company will no longer be a subsidiary of the company, and its financial performance, assets and liabilities will no longer be consolidated into the Group's comprehensive financial statements.